Amedisys (AMED) Tops Q4 EPS by 1c, Revs Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Amedisys Reports Fourth Quarter and Year End 2019 Financial Results and Issues 2020 Guidance
February 18, 2020 4:15 PM ESTBATON ROUGE, La., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period and year ended December 31, 2019.
Three Month Periods Ended December 31, 2019 and 2018
Net service revenue increased $66.3Â million to $500.7Â million compared to $434.4Â million in 2018.Net income attributable to Amedisys, Inc. of $27.7Â million compared to $27.5Â million in 2018.Net income attributable to Amedisys, Inc. per diluted share of $0.83 compared to $0.84 in 2018.Adjusted Quarterly Results*
Adjusted EBITDA of $52.2Â million compared to $43.9Â million in 2018.Adjusted net service revenue of $500.7Â million compared to $434.4Â million in... More